Expression, roles, receptors, and regulation of osteopontin in the kidney  by Xie, Yuansheng et al.
Kidney International, Vol. 60 (2001), pp. 1645–1657
PERSPECTIVES IN BASIC SCIENCE
Expression, roles, receptors, and regulation of osteopontin in
the kidney
YUANSHENG XIE, MINORU SAKATSUME, SHINICHI NISHI, ICHIEI NARITA, MASAAKI ARAKAWA,
and FUMITAKE GEJYO
Department of Medicine (II), Niigata University School of Medicine, Niigata, Japan
Expression, roles, receptors, and regulation of osteopontin in injury. In addition, reviews about receptors and regula-
the kidney. Osteopontin (OPN) is a secreted glycoprotein in tion of OPN in the kidney are limited. This review intro-
both phosphorylated and non-phosphorylated forms. It con- duces a generalization of OPN and describes the expres-tains an Arg-Gly-Asp cell-binding sequence and a thrombin-
sion, roles, receptors and regulation of OPN in normal,cleavage site. OPN is mainly present in the loop of Henle and
abnormal, animal and human kidneys referring to typicaldistal nephrons in normal kidneys in animals and humans.
After renal damage, OPN expression may be significantly up- reports in relation to “OPN and kidney” since 1986, the
regulated in all tubule segments and glomeruli. Studies utiliz- “birth” of OPN [2] to 2001, using evidence from humans,
ing OPN gene-deficient mice, antisense-treated or anti-OPN- OPN gene-deficient, antisense-treated or anti-OPN anti-treated animals have demonstrated that OPN promotes accu-
body-treated animals.mulation of macrophages, and may play a role in macrophage-
mediated renal injury, but that the effect may be mild and
short-lived. On the other hand, OPN has some renoprotective
GENERALIZATION OF OPNactions in renal injury, such as increasing tolerance to acute
ischemia, inhibiting inducible nitric oxide synthase and sup- Osteopontin also is known as a 44 kD bone phospho-
pressing nitric oxide synthesis, reducing cell peroxide levels
protein, sialoprotein I, secreted phosphoprotein I, 2ar,and promoting the survival of cells exposed to hypoxia, decreas-
uropontin and early T-lymphocyte activation-1 (Eta-1)ing cell apoptosis and participating in the regeneration of cells.
In addition, OPN is associated with renal stones, but whether [2–6]. OPN cDNA clones initially isolated from a rat
it acts as a promoter or inhibitor of stone formation is contro- osteosarcoma (ROS 17/2.8) phage gt11 library have a
versial. It has been demonstrated that OPN receptors include 1473-base-pair-long insert that encodes a protein with
two families: integrin and CD44. The OPN integrin receptors
317 amino acid residues. Because it is a product of cellsinclude v3, v1, v5 and 91, and 41. In normal human
in the osteoid matrix and can form a bridge (Latin pons)kidneys, standard CD44 is expressed most dominantly. Differ-
ent OPN functions are mediated via distinct receptors. Parathy- between cells and the mineral in the matrix, it was named
roid hormone, vitamin D3, calcium, phosphate and some cyto- “osteopontin” by Oldberg et al in 1986 in order to better
kines increase OPN expression in vitro or in vivo, whereas reflect the potential function of this protein [2].female sex hormones and angiotensin-converting enzyme in-
Osteopontin is synthesized at the highest levels in bonehibitors or angiotensin II receptor antagonists decrease OPN
and epithelial tissues [7]. It also is expressed in an assort-expression in some renal damage states.
ment of other cell types, including macrophages [8], acti-
vated T cells [9], smooth muscle cells [4] and endothelial
cells [10]. OPN is synthesized by preosteoblasts, osteo-Osteopontin (OPN), a secreted glycoprotein, is pres-
blasts and osteocytes as a bone matrix protein, secretedent in normal kidneys, has up-regulated expression and
many potential roles in abnormal kidneys. Although a into osteoids and incorporated into bone. In addition to
review regarding the expression and role of OPN in renal bone cells, OPN is synthesized by extraosseous cells, as
disease has been published [1], there are few data from well as by odontoblasts, certain bone marrow cells and
humans, or direct evidence that OPN plays a role in renal hypertrophic chondrocytes. Several types of fibroblasts
and epithelial-derived cell lines in culture can secrete
OPN [11].Key words: osteopontin, macrophage, apoptosis, regeneration, integ-
rin, CD44. Widely distributed in normal adult human tissues,
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brain, deciduum, placenta and arteries [4, 11, 12]. It also ment, and dampens the IL-10 response through CD44
engagement [6]. The thrombin cleavage of OPN allowsis present in body fluids such as urine and milk [7].
Osteopontin isolated from rat bone is a 44 kD glycosy- greater accessibility of the RGD domain to cell surface
receptors. The integrin 91 binding site in OPN is cryp-lated phosphoprotein. The OPN secreted by normal rat
kidney (NRK) cells in vitro is a 69 kD glycoprotein in both tic, but is revealed after thrombin cleavage [23]. Throm-
bin cleavage enhances the accessibility of the bindingphosphorylated (pp69) and non-phosphorylated (np69)
forms. The pp69 forms a heat-stable complex with cell motif for integrin V3 on OPN [24].
Integrin-mediated cell survival involves regulation ofsurface fibronectin, whereas the np69 contains N-linked
carbohydrates and forms a heat-dissociable complex with nuclear factor-B (NF-B) activity. OPN and 3 integrin
ligation rapidly increased NF-B activity. V3 integrinplasma fibronectin, suggesting functional modulation of
OPN by phosphorylation [13]. For example, dephosphory- was the most important for OPN-mediated NF-B induc-
tion and survival, since adding a neutralizing anti-3 in-lation of purified, naturally produced OPN abolishes in-
terleukin-12 (IL-12) stimulatory activity; phosphoryla- tegrin antibody blocked NF-B activity. NF-B was re-
quired for OPN- and vitronectin-induced survival, as thetion of recombinant OPN at specific sites restores this
activity [6]. Sequence analysis of this cDNA revealed inhibition of NF-B activity with non-phosphorylatable
I-B completely blocked the protective effect of OPNthe presence of a 52-nucleotide-long insert in the 5-non-
coding region, which was absent in OPN cDNA cloned and vitronectin. Activation of NF-B by OPN depended
on the small GTP-binding protein Ras and the tyrosinefrom the cDNA library of ROS 17/2.8 rat osteosarcoma
cells [14]. kinase Src, since Ras and Src dominant-negative mutants
inhibited NF-B reporter activity. These studies identifyAn important structural characteristic of OPN is that
it contains a glycine-arginine-glycine-aspartate-serine NF-B as an important signaling molecule in V3 integ-
rin-mediated cell survival [25].(GRGDS or RGD) amino acid sequence, which is iden-
tical to the cell-binding sequence identified in fibro- The expression of OPN is up-regulated in the injury
nectin [2]. and recovery processes of a lot of tissues and cells, includ-
Another interesting feature of OPN’s structure is the ing inflammation, fibrosis, mineralization and regenera-
presence of a thrombin-cleavage site in close proximity tion of bone, kidneys, heart, vessels and cultured cells
to the RGD region (the RGD sequence in OPN is only [1, 4, 7, 10, 17–20, 26]. Its expression is regulated by many
six residues from the thrombin-cleavage site). OPN can factors including hormones, growth factors, cytokines,
be cleaved into two fragments by thrombin, an amino vitamin D3, calcium, phosphate and drugs (Table 1).
(N)-terminal fragment and a carboxyl (C)-terminal frag-
ment. For all cell lines examined, thrombin-cleaved OPN
EXPRESSION OF OPN IN NORMALLYpromoted markedly greater cell attachment and spread-
DEVELOPING AND ADULT KIDNEYSing than uncleaved OPN [15]. The N-terminal fragment
Expression of OPN in normal kidneys depends on thecontaining the RGD motif promoted enhanced adhesion
type of animal (Fig. 1), and its age and gender.of mouse and human fibroblasts 2.9- and 2.8-fold in com-
In mice, OPN mRNA was detected in postnatal kidneyparison with full-length OPN, respectively. The enhan-
tubules at 14.5 d p.c. during embryogensis by Northernced adhesion of both cells mediated by the N-terminal
blot analysis and in situ hybridization [27]. Both methodsfragment was significantly suppressed by addition of a
of in situ hybridization with a mouse cDNA probe, andC-terminal fragment lacking the RGD motif, which has
immunohistochemical staining with three different anti-less cell adhesive property than full-length OPN [16].
sera to mouse OPN, revealed that OPN expression in theOsteopontin is associated with a number of functions
normal mouse kidney is primarily restricted to the thickinvolving regulation of osteoclast function during bone
ascending limbs of the loop of Henle and distal convo-formation, renal stone formation, tumorigenesis and trans-
luted tubules. The protein is detected predominantly atformation, and accumulation of macrophages [7, 17]. In
the apical surface of cells lining the lumen of a subset ofaddition, it has immune functions [6–9], inhibits induc-
tubules. OPN expression is not detected in healthy glo-tion of inducible nitric oxide synthase (iNOS) [18], and
meruli, proximal tubules, thin limbs of the loop of Henle,protects cells from apoptosis [19] as a survival factor.
collecting ducts, or interstitial fibroblasts. Relative to maleRecently, we demonstrated that OPN is associated with
mice, OPN expression is somewhat higher in female, preg-cell proliferation and regeneration in the recovery pro-
nant and lactating mice and markedly increases in thecess after renal injury [20].
parietal epithelium of glomeruli undergoing sclerosis inThe effects of OPN are achieved by its receptors,
aging mice. OPN also is detected in the macula densa.which include integrin families and CD44 families [21,
These results suggest that OPN is synthesized and se-22]. For example, the production of OPN by activated
creted into the tubule fluid by the luminal epithelia ofT cells is an essential proximal event that potentiates the
macrophage IL-12 response through integrin engage- distal portions of a subset of kidney nephrons [28].
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Table 1. Generalization of osteopontin
Item Contents References
Name Osteopontin, 44 kD bone phosphoprotein, sialoprotein I, 2ar, secreted phospho- [2–6]
protein I, uropontin and early T-lymphocyte activation-1
Synthesis Bone or extraosseous cells, epithelial or epithelial-derived cells, macrophages, [7–11]
activated T cells, smooth muscle cells and endothelial cells
Normal distribution Bone tissue, epithelial tissue, kidney, artery, inner ear, brain, deciduum, placenta, [4, 7, 11, 12]
urine and milk
Modular volume 44 kD (isolated from rat bone); 69 kD (secreted by normal rat kidney cells) [3, 13]
Structural characteristic Arg-Gly-Asp sequence, thrombin-cleavage site, phosphorylated and non-phosphorylated [2, 13, 15]
forms
Roles Adhesion, migration, signaling, biomineralization, immunity and survival action [6–9, 17–21]
Receptors Integrin, CD44 [21, 22]
Regulation Increase: parathyroid hormone, vitamin D3, calcium, phosphate, growth factor, cytokines [32, 37, 42, 46, 52]
Inhibit: female sex hormone, low salt, drugs [94–105]
In situ hybridization with labeled RNA made from
cDNA containing the entire coding sequence for mouse
OPN reveals messages at the same sites at which the
protein is demonstrated by immunocytochemistry. Im-
munogold labeling is localized to a population of dense
vesicles distinct from lysosomes and endosomes. To ex-
amine the turnover of OPN, rats were injected with the
protein synthesis inhibitor, cyclohexamide, six hours
prior to kidney fixation. These kidneys no longer demon-
strated OPN in the TDL, and the immunofluorescence
in the papillary surface was attenuated [30]. The results
also suggest that OPN is synthesized and secreted into
the tubule fluid by the luminal epithelia of distal portions
of a subset of kidney nephrons. Occasionally, OPN im-
munostaining of individual cells is observed in the pars
Fig. 1. Expression of osteopontin (OPN) in normal adult kidneys. OPN recta (S3 segment) of proximal tubules at the transitionexpression in normal mouse kidneys is primarily restricted to the thick
to the TDL. Weak immunostaining is observed in manyascending limbs of the loop of Henle and distal convoluted tubules. In
normal rat kidneys, OPN is primarily present in the descending thin thick ascending limb segments in the medulla. Transmis-
limbs of the loop of Henle in the outer medulla. In normal human
sion electron microscopy confirms the presence of strongkidneys, OPN is localized primarily to the distal nephrons and is strongly
expressed by the thick ascending limbs of the loop of Henle. OPN immunoreactivity in TDL cells and the papillary
surface epithelium. In the TDL, labeling is located in
the Golgi apparatus and in small cytoplasmic vesicles
and small dense bodies with the appearance of secretoryIn rats, OPN mRNA is present in kidneys obtained
granules. A few proximal tubule cells show weak stainingfrom embryos as early as embryonic day 13 (E13). Immu-
of lysosome-like structures [31]. Northern blot analysisnohistochemical staining of metanephroi obtained from
shows that expression of OPN mRNA is stimulated pow-E16 rat embryos, as well as metanephroi obtained from
erfully in old rats. Dot-blot quantitation analysis showedE13 embryos and cultured for three days in vitro, demon-
that OPN mRNA increased 3.1- and 9.1-fold, respec-strated that OPN is expressed both in developing neph-
tively, in 12- and 24-month-old rats [32].rons and in the ureteric bud [29]. In an early immunohis-
In human fetal, and normal mature, renal tissue, immu-tochemical study in newborn rats, OPN was found only
nohistochemistry, immunoelectron microscopy, in situin the proximal tubules [3]. Because immunostaining
hybridization and Northern blotting show that OPN pro-is observed in components of the vacuolar-lysosomal
tein and mRNA are expressed in the human embryonicsystem, it was concluded that OPN is absorbed from the
renal tubular epithelium beginning on approximatelytubule fluid. However, most later studies (including our
day 75 to 80 of gestation. In the fetal kidney, OPN alsostudy) do not support this result [20, 30–32]. Fluores-
can be occasionally seen expressed in the ureteric budscence, confocal and electron microscopy revealed OPN
and in some interstitial cells. As localized at the proteinprimarily in cells of the thin descending limb (TDL) of
and mRNA level, the tubular expression of OPN in-the loop of Henle in the outer medulla and in the papil-
lary surface epithelium in the area of the calyceal fornix. creases with increasing gestational age and persists into
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Table 2. Expression of osteopontin in experimental models of renal injury
Reasons Injury models Animals G BC PCT PST TL DST DCT CD CT Methods References
Glyoxylic acid Renal stone Rats        ISH, IHC, N [36–38]
Angiotensin II Tubulointerstitial nephritis Rats     ISH, IHC, N, W [39]
Puromycin, Thy-1 Glomerulonephritis Rats      ISH, IHC [5, 40]
Ischemia Acute renal injury Rats     ISH, IHC, N [41–43]
Bovine albumin Interstitial fibrosis Rats  IHC, N [44]
Ureteral obstruction Hydronephrosis Rats  ISH, IHC, N, W [45, 46]
Cyclosporine Nephropathy Rats  IHC [47, 48]
Hypercholesterol Interstitial fibrosis Rats  IHC, N [49]
Anti-GBM serum Crescent glomerulonephritis Rats       ISH, IHC, N [50]
5/6 nephrectomy Chronic renal failure Rats     IHC [51, 52]
Streptozotocin Diabetic nephropathy Rats     IHC, [53]
Autoimmune Lupus nephritis Mice   ISH, IHC, N [54]
Phenylephrine Hypertension Rats     IHC [55]
Gentamicin Acute tubular necrosis Rats        ISH, IHC, N [20]
Abbreviations are: G, glomerular tuft; BC, Bowman’s capsule; PCT, proximal convoluted tubule; PST, proximal straight tubule (thick descending limb); TL, thin
limb of loop of Henle; DST, distal straight tubule (thick ascending limb); DCT, distal convoluted tubule; CD, collecting duct; CT, cortical tubule; GBM, glomerular
basement membrane; ISH, in situ hybridization; IHC, immunohistochemistry; N, Northern blot analysis; W, Western blot analysis.
adulthood. In the normal adult kidney, OPN is localized increase in OPN mRNA in stone-forming rats in propor-
tion to the dosage and duration of stone-inducing drugsprimarily to the distal nephrons and is strongly expressed
by the thick ascending limb of the loops of Henle. OPN [36, 37]. In other rat models of renal stones, OPN in-
creased in all segments of renal tubules, including theexpression also can be observed in some collecting duct
epithelia. In cases that exhibit interstitial fibrosis foci proximal tubules (S3 	 S2 	 S1), distal tubules, limbs
of Henle and collecting ducts, and the papillary surfaceand an associated influx of interstitial macrophages, OPN
expression is significantly up-regulated in all tubule seg- epithelium [38]. These results suggest that OPN is associ-
ated with renal stones.ments, including proximal tubules [33].
In angiotensin II-induced tubulointerstitial nephritis,
preceding pathologic changes in tubular and interstitial
EXPRESSION OF OPN IN RENAL
cells, a dramatic increase in renal OPN protein and
DAMAGE CONDITIONS
mRNA levels is observed primarily in epithelial cells of
Osteopontin has been examined in various experimen- the distal tubules, collecting ducts and Bowman’s cap-
tal models of renal injury (Table 2). Recently, expression sule. Regions of the kidney expressing high OPN levels
of OPN in human renal carcinomas, essential hyperten- correlate with sites of monocyte/macrophage accumula-
sion, progressive idiopathic membranous nephropathy, tion [39].
crescentic glomerulonephritis, immunoglobulin A ne- In experimental models of glomerulonephritis such as
phropathy (IgAN), diffuse proliferative lupus nephritis, puromycin nephrosis, anti-Thy-1 nephritis and passive
minimal change nephrotic syndrome and human renal Heymann nephritis, OPN mRNA and protein levels are
allografts has been reported. up-regulated in a portion of proximal and distal tubules.
In all three models, the expression of OPN initially pre-
Expression of OPN in experimental models of cedes histological evidence of tubular injury, but is corre-
renal injury lated with subsequent sites of monocyte/macrophage
When analyzing the chemical nature of urinary cal- accumulation and tubular damage. OPN expression also
cium oxalate stone protein as early as 1992, Kohri et al correlates with the severity of the tubulointerstitial injury,
found that cDNA sequences of a protein in a urinary being greatest in amino-nucleoside nephrosis [5, 40].
stone had exactly the same identity as human OPN, In a model of acute ischemic renal injury, levels of
demonstrating that urinary stones consist of OPN pro- whole kidney OPN mRNA in rats rendered ischemic
tein [34]. A later study identified that the OPN protein one day previously were elevated approximately 18-fold
is present around microcrystals of renal papillary stones compared to levels measured in sham-operated controls,
on reflection-contrast light microscopical images with a as determined by Northern analysis. In situ hybridization
high-resolution transmission-electron microscope [35]. demonstrated that the elevated expression of OPN one
In rat models of stone formation induced by glyoxylic day postinjury was localized predominantly to cells in
acid, OPN mRNA and protein in distal tubular cells is the distal tubule and medullary thick ascending limb of
markedly increased, but proximal tubular cells and glo- Henle’s loop. Immunostaining showed an identical local-
meruli are negative with in situ hybridization and immu- ization for elevated protein expression. Five days post-
injury, OPN peptide and mRNA were detected clearlynostaining. Northern blot analysis showed a significant
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in regenerating proximal tubules, in addition to distal lesions and, notably, crescent formation; this also pre-
ceded, and correlated with, interstitial macrophage andtubules and the medullary thick ascending limb [41].
In a rat model of ischemia-induced acute renal failure, T-cell infiltration. Both glomerular and tubular OPN
expression correlated significantly with proteinuria andNorthern analysis of kidney cortical RNA showed a
time-dependent increase in OPN mRNA expression that a reduction in creatinine clearance. In addition, strong
OPN mRNA and protein expression are seen in macro-was significantly higher than in sham-operated rats [42].
After ischemia/reperfusion, all examined nephron seg- phages and multinucleated giant cells [50].
In remnant kidneys, in a 5/6 renal mass ablation model,ments showed a significant increase in OPN expression,
but the time courses and staining pattern of OPN up- OPN was detectable in proximal tubules and distal tubu-
lar segments containing casts or showing signs of atrophyregulation were different in proximal and distal tubules.
The distal tubules showed an early and persistent in- and thickened basement membranes [51]. In another
study, following subtotal (5/6) nephrectomy (weeks 2 tocrease in OPN staining with a maximum 24 hours after
reperfusion, followed by a slow decrease in the absence 16), there was substantial up-regulation of OPN mRNA
and protein expression in glomeruli and tubular epithe-of major morphological injury, whereas OPN staining in
the proximal tubules was delayed, with a maximum after lial cells. The up-regulation of OPN expression was asso-
ciated with macrophage accumulation within the kidney,five to seven days, and was mostly associated with mor-
phological regeneration, higher in the outer stripe of the severe proteinuria, loss of renal function, and severe
histologic damage, including tubulitis and tubulointersti-outer medulla than in the cortex [43].
In an interstitial inflammation and fibrosis model with tial fibrosis [52].
In a rat model of streptozotocin-induced diabetes,significant proteinuria induced by daily injections of bo-
vine serum albumin, whole kidney OPN mRNA levels Northern blot analysis revealed a time-dependent up-
regulation of renal cortical OPN expression reachingwere significantly elevated in the renal cortex from the
fourth day. After two and three weeks, OPN mRNA levels 138  6% of the control levels after two weeks and
290  30% after 12 weeks. During this period of time,increased and the proteins showed distinct tubular pat-
terns of distribution, respectively [44]. diabetic nephropathy developed, as characterized by a
reduced glomerular filtration rate and proteinuria. Im-In experimental hydronephrosis after unilateral ure-
teral obstruction (UUO), OPN mRNA levels in ob- munostaining showed that increased OPN expression
was present in the tubular epithelium of the renal cortex.structed kidneys increased versus contralateral unob-
structed specimens as early as four hours after UUO. Increased levels of OPN are not associated with accumu-
lation of monocyte/macrophages identified by the cellOPN mRNA and protein increases reached fourfold after
one day of UUO, and persisted at this level for the five- type-specific monoclonal antibody, ED-1 [53].
In MRL-Fas (lpr) mice with lupus nephritis, immuno-day duration of UUO. Focal labeling of OPN is noted
in both the tubular and Bowman’s capsular epithelium fluorescence staining, Northern blot analysis, and in situ
hybridization revealed prominent expression of OPN byin obstructed kidneys, whereas in contralateral unob-
structed specimens, there is only faint staining in Bow- proximal tubules in MRL-Fas (lpr) mice, but not in con-
trol mice. The enhanced OPN expression correlated withman’s capsule. Paralleling the increments in renal corti-
cal OPN mRNA levels, the number of macrophages diffuse macrophage infiltration in the kidneys of MRL-
Fas (lpr) [54].was significantly elevated in the cortical renal intersti-
tium [45, 46]. In a rat model of hypertension induced by phenyl-
ephrine infusion, glomeruli were largely spared, but focalIn a salt-depleted rat model of chronic cyclosporine
nephropathy, increased cortical tubular staining for OPN tubulointerstitial fibrosis was present, with the de novo
expression of OPN by injured tubules, macrophages andcorrelated with a significant macrophage influx and inter-
stitial fibrosis by day 35 [47, 48]. myofibroblast accumulation [55].
In another rat model of gentamicin-induced acute tu-In a rat model of interstitial inflammation and fibrosis
with diet-induced hypercholesterolemia, renal cortical bular necrosis, OPN mRNA and protein were found
markedly not only in proliferating cortical distal tubules,OPN mRNA and protein levels increased significantly,
accompanied by albuminuria and interstitial monocyte but also in regenerative proximal tubules by in situ hy-
bridization and double immunohistochemical staining.infiltration, after 12 weeks [49].
In a rat model of accelerated anti-glomerular base- The expression of OPN in the medullary tubules was
stronger than that of the control [20].ment membrane (GBM) glomerulonephritis, there was
marked up-regulation of OPN mRNA and protein expres-
Expression of OPN in human renal diseasession by glomerular visceral and parietal epithelial cells
and tubular epithelial cells. Glomerular OPN expression Osteopontin is overexpressed in the tissues of a variety
of experimental malignancy models. In carcinoma of thepreceded, and correlated with, macrophage infiltration in
the development of hypercellularity, focal and segmental human kidney, tumor cells and host macrophages strongly
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express OPN mRNA. The presence of OPN mRNA in from some patients with MCNS or MN but was absent
in normal subjects. Thrombin treatment of the urinemacrophages is particularly pronounced at the edge of
tumors and in areas of tumor necrosis. Although in most from normal controls resulted in 34 kD OPN fragments.
Although the underlying mechanisms remain to be de-cases tumor cells do not label detectably for OPN mRNA,
both tumor cells and macrophages stain for OPN protein, termined, these data provide evidence that secretion or
processing (or both) of urinary OPN is altered in patientssuggesting that OPN secreted by macrophages may bind
to tumor cells, possibly through the GRGDS cell-binding with IgAN [61].
In human renal allografts, strong OPN expression bydomain in OPN [56].
In renal biopsies from patients with essential hyperten- the proximal tubular epithelium (PTE) was observed in
the majority of pre-transplant donor biopsies, as well assion with decompensated arteriolosclerosis, OPN mRNA
and protein are increased in tubules in association with early post-transplant biopsies. In patients that did not
experience episodes of rejection, OPN expression byexpression of -smooth muscle actin by interstitial fibro-
blasts and increased type IV collagen deposition [57]. PTE decreased substantially, as seen in protocol biopsies
taken one year post-transplant. In biopsies with eitherIn human progressive idiopathic membranous nephrop-
athy patients, a strong up-regulation of monocyte chemo- cellular or vascular rejection, OPN expression by PTE
was widespread and intense, and correlated with macro-attractant protein-1, regulated on activation normal T cell
expressed and secreted (RANTES) chemokine and OPN phage infiltration. In biopsies with cyclosporine toxicity,
OPN expression by PTE was moderate compared withwas observed, mainly in tubular epithelial cells, with a
significant major intensity. A strong correlation between rejection biopsies, but was equally widespread and with-
out demonstrable association with macrophage infiltra-OPN mRNA expression and the corresponding protein
was noted. The presence of these chemokines is associ- tion. These data suggest that OPN expression by PTE
is up-regulated in human allografts most likely in re-ated with interstitial cell infiltration [58].
In human crescentic glomerulonephritis, macrophages, sponse to ischemia (pre-transplant and cyclosporine tox-
parietal epithelial cells, CD3-positive T cells, or -smooth icity biopsies), and that further up-regulation of OPN
muscle actin-positive myofibroblasts present in the glo- in rejection may contribute to the influx of monocytes/
merular crescent expressed OPN protein and mRNA at macrophages into the tubulointerstitium (abstract; Hud-
a high level. Interstitial monocyte/macrophages did not kins et al, J Am Soc Nephrol 11:A3497, 2000).
express OPN, except when located in a periglomerular
inflammatory infiltrate [59].
ROLES OF OPN IN RENAL PATHOLOGYIn patients with IgA nephritis (IgAN) and diffuse pro-
AND PATHOPHYSIOLOGYliferative lupus nephritis, OPN expression was up-regu-
Osteopontin has a number of diverse biological func-lated in the cytoplasm of the proximal and distal tubular
tions, including cell adhesion, migration, signaling, bio-epithelium parallel to the degree of interstitial mononu-
mineralization, immunity, and survival action. In the kid-clear cell infiltration. CD68() monocyte infiltration sig-
ney, OPN may be associated with renal stones andnificantly correlated with the degree of OPN expression
accumulations of monocytes/macrophages in injured tis-in the tubular epithelium. Conversely, there was no ap-
sue. In some settings, OPN may act as a survival factorparent induction of OPN in the proximal and distal tubu-
for renal cells (Table 3).lar epithelium of patients with myeloperoxidase-antineu-
trophil cytoplasmic autoantibody-associated microscopic
Role of OPN during renal development and inpolyangiitis, despite marked monocyte infiltration. These
normal kidneysdata suggest that inducible expression of OPN in the
Osteopontin may not play an essential role duringtubular epithelium seems to be associated with intersti-
renal development because in OPN-deficient mice, kid-tial monocyte infiltration and subsequent tubulointersti-
ney development is entirely normal, and histologicallytial changes in some forms of human renal diseases [60].
the kidney has no evidence of abnormalities [17], al-Additionally, compared with normal controls, the
though the addition of anti-OPN antibodies to meta-mean  SD of urinary OPN in IgAN patients was de-
nephric organ cultures results in failure of the metaneph-creased significantly (21.4 6.2 vs. 11.6 9.6 mg/g creati-
ric blastema to undergo normal tubulogenesis [29].nine, P 
 0.001). In contrast, the levels of urinary OPN
In addition, it appears that OPN does not play anin patients with minimal-change nephrotic syndrome
essential role in normal kidney cell function per se. This(MCNS) or membranous nephropathy (MN) did not dif-
conclusion derives both from the normal morphology offer significantly from normal values. Immunoblot analy-
the OPN-deficient kidneys, as well as from studies onsis showed that OPN is present as a 55 to 60 kD molecule
the expression of OPN protein in the normal kidney [17].in normal urine. A 34 kD fragment of OPN was the
The OPN protein is present at very low levels in themajor immunoreactive band in samples from IgAN pa-
tients. This fragment also was detectable in the urine normal kidney tissue, and is undetectable by Western
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Table 3. Roles of osteopontin (OPN) in the kidneys
Angles Possible roles References
Renal development No essential role [17]
Normal kidney No essential role [17]
Inhibiting calcium oxalate formation? [17]
Renal stone formation Inhibiting crystal growth, adherence, aggregation and nucleation [64–69]
Increasing crystal deposition and adhesion [70–72]
Renal injury Mediating early interstitial macrophage influx and interstitial fibrosis [5, 19, 54]
Contributing to glomerular crescent formation or not [74–76]
Renal protection Inhibiting iNOS levels and suppressing NO synthesis [77, 79]
Reducing cell peroxide levels [80]
Decreasing interstitial and tubular cell apoptosis [19]
Participating in regeneration and repair of tubular cells [20, 41, 43, 81]
blotting techniques [62]. Our study also demonstrated calcium oxalate monohydrate (COM) aggregation at
concentrations similar to those that inhibit COM growth,that OPN was present at very low levels in normal kidney
tissue, especially in the renal cortex [20]. with a mean concentration of 28  4 nmol/L required
for a 50% reduction in aggregation and 16  2 nmol/LHowever, OPN is found at high levels in urine. Min
et al demonstrated that daily urinary OPN excretion in required for a 50% reduction in growth. The concentra-
tions of uropontin in normal urine (131  13 nmol/L)13 normal young adult human volunteers was 3805 
1805 g/24 h (mean 1 SD) and the mean urinary levels exceed the levels that substantially decrease calcium oxa-
late crystal growth and aggregation. In contrast, the 50%were 1.9 g/mL [63]. Gang et al reported that mean 
SD of urinary OPN in 20 normal humans was 21.4  6.2 inhibition of COM nucleation using a seeded nucleation
assay occurred at a concentration of human uropontinmg/g creatinine [61]. Apparently, the majority of OPN
(200 nmol/L) that was roughly tenfold higher than themade in the kidney is destined for export to the urine.
concentrations required for the equivalent inhibition ofThere, it likely functions as an inhibitor of calcium oxa-
crystal growth, aggregation or adherence to renal epithe-late formation, helping to prevent mineral precipitation
lial cells. These studies using a seeded nucleation assayin this supersaturated fluid. However, this viewpoint is
suggest that uropontin only modestly contributes to nu-controversial (detailed in the next section).
cleation inhibition. However, studies using an unseeded
OPN roles in inhibiting or promoting renal nucleation assay showed inhibition of nucleation at con-
stone formation centrations of mouse OPN as low as 10 nmol/L [68].
These latter studies indicate a much greater capacity forOsteopontin is one of the most important components
in the renal calcium stone matrix, and is up-regulated in inhibition of nucleation.
In addition, OPN also favors formation of calcium oxa-renal tubules, especially distal tubules, in experimental
models and renal stone patients. However, whether it late dihydrate (COD) over COM crystals in vitro. COD
is less (50%) adherent to renal epithelial cells than COM,acts as an inhibitor or promoter of stone formation is
also controversial. suggesting that OPN may prevent calcium oxalate neph-
rolithiasis by inducing COD formation [69]. In a modelInhibiting renal stone formation. The majority of hu-
man urinary stones are primarily composed of calcium of calcium oxalate formation in OPN knockout, hetero-
zygote, and wild-type mice by exposing them to 1% ethyl-salts. Although normal urine is frequently supersatu-
rated with respect to calcium oxalate, most individuals ene glycol, COD crystals were detected in the urine from
all mice, but, importantly, were enriched in the urine ofdo not form stones. This suggests that there are some
factors inhibiting urinary stone formation. A potent crys- wild-type mice. Numerous intratubular COM crystals
were seen in thin sections from knockout mice kidneystal growth inhibitor is present in the conditioned media
from primary cultures of mouse kidney cortical cells. after four weeks of exposure to ethylene glycol. These
results suggesting that OPN directed formation of CODConditioned media incubated with the kidney cells for
6 to 72 hours, resulted in the inhibitory activity on crystal in preference to COM may represent an important and
novel mechanism to protect the kidney from calciumgrowth increasing 15-fold within 24 hours. The sequence
of the N-terminal 21 amino acids of this inhibitor matches oxalate crystal deposition (abstract; Beshensky et al,
J Am Soc Nephrol 11:A2948, 2000).that of OPN [64].
Uropontin, the urinary form of OPN, has been shown Promoting renal stone formation. Some reports sug-
gest that OPN plays an important role in the process ofpreviously to reduce growth [65] and aggregation [66]
of calcium oxalate crystals, and block the binding of the stone formation. In vitro, the 45Ca concentration in calcium
oxalate crystals adhering to Madin-Darby canine kidneycrystals to renal epithelial cells [67]. Uropontin inhibits
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(MDCK) cells was about 1.4 times higher in MDCK cells mild and short-lived in mediating macrophage accumula-
tion [19].incubated with OPN than in a control group, and was
In accelerated crescentic glomerulonephritis, up-regu-about one half that in MDCK cells incubated with throm-
lated OPN expression precedes and correlates with mac-bin than in the control group [70].
rophage infiltration in the development of hypercellular-With the aid of the lipofection reagent, DOTAP, Ya-
ity and crescent formation; this also precedes andmate et al introduced antisense and sense oligonucleo-
correlates with interstitial macrophage and T cell infil-tides corresponding to an appropriate part of the coding
tration. Anti-OPN treatment significantly reduced glo-sequence for OPN into MDCK cells grown in a confluent
merular injury (urinary protein excretion) and preventedmonolayer. After further incubation, inhibition of OPN
loss of renal function (creatinine clearance) during theexpression in the cells was assessed by immunofluores-
induction of disease. This was accompanied by a signifi-cence photomicrography, while formation of calcium
cant reduction in renal macrophage and T-cell accumula-oxalate crystals was quantitated by incorporation of 45Ca
tion, T-cell activation, and histological injury (glomeru-into the stone and visualized via scanning electron micros-
lar hypercellularity, segmental lesions, crescents, andcopy. As a result, antisense oligonucleotides at concen-
tubulointerstitial lesions). An important finding was thattrations higher than 20mol/L inhibited synthesis of OPN.
anti-OPN treatment of established crescentic glomerulo-Incorporation of 45Ca into a calculus stone was inhibited
nephritis led to a significant reduction in glomerular in-by the addition of an oligonucleotide in a concentration-
jury and recovery of renal function in association withdependent manner in a range above 20 mol/L. More
inhibition of macrophage and T-cell accumulation, T-cellthan 90% of incorporation was inhibited at 50 mol/L
activation, and histological damage [74]. Intravenouslyas compared to a control. This suggests that OPN plays
injecting an OPN antisense oligodeoxynucleotide intoan important role in stimulating deposition and adhesion
Goodpasture syndrome rats, in parallel with blockadeof calculus crystals to cells in the early stages of urolithi-
of tubular OPN expression, significantly attenuatedasis [71].
monocyte infiltration and preserved renal plasma flow,To determine the degree to which this increased depo-
compared with sense oligodeoxynucleotide-treated andsition of calcium oxalate crystals on the surface of MDCK
untreated Goodpasture syndrome rats [75]. These resultscells is caused by OPN, MDCK cells (2  106 cells/well)
suggest that OPN plays a functional role in macrophagewere cultured to a confluent state, and the binding of
and T-cell accumulation and renal damage in both theOPN to the cellular surface was then inhibited by adding
induction and progression of a rat model of crescentican anti-OPN polyclonal antibody. The cells were cul-
glomerulonephritis.tured for 24 hours. The degree of calcium oxalate crystal
However, there is some contrary evidence. For exam-
deposition was inhibited for 80% or more in the anti-
ple, no significant changes were observed in the histopa-
body-treated group, and for 50 to 80% in the thrombin- thology of the glomeruli after OPN antisense or sense
treated group [72]. These results suggest that intact OPN oligodeoxynucleotide treatment in Goodpasture syn-
in the extracellular matrix may be the cause of calcium drome rats [75]. Additionally, in rapidly progressive glo-
oxalate crystal deposition on the surface of MDCK cells, merulonephritis in OPN knockout mice, proteinuria was
whereas thrombin-cleaved OPN may inhibit calcium ox- also similar, compared with OPN wild-type mice. Glo-
alate crystal deposition. merular crescent formation was not different in OPN/
Additionally, OPN had no effect on the binding of and OPN/ groups (26  6% vs. 29  7%). Tubuloin-
uric acid crystals to the surface of monkey kidney epithe- terstitial infiltration was assessed qualitatively and
lial cells in vitro [73]. showed no significant difference between the two geno-
types. Formation of thrombi in the glomerular capillariesOPN roles in renal injury
on a scale from 0 to 3 also showed no significant differ-
As in the prior descriptions, after some renal injuries, ence (1.3  0.3 for OPN/ and 1.4  0.3 for OPN/
regions of OPN up-regulated expression are usually cor- mice). It is concluded that the known up-regulation of
related with sites of subsequent or synchronous mono- OPN in murine anti-GBM nephritis does not signifi-
cyte/macrophage accumulation [5, 40, 41, 54]. Macro- cantly contribute to the glomerular and tubulointerstitial
phage influx was less in OPN/ mice compared to mononuclear cell infiltration in this model [76].
OPN/ mice on day 4 (threefold, P 
 0.02), day 7
Role for OPN as a renoprotective factor(fivefold, P
 0.02), but not on day 14. Interstitial deposi-
tion of types I and IV collagens were also two- to fourfold In an experimental model of renal ischemia, mice with
less in obstructed OPN/ kidneys (P 
 0.02). These a disrupted OPN gene exhibited ischemia-induced renal
results suggest that OPN may mediate early interstitial dysfunction that was twice as pronounced as that ob-
macrophage influx and interstitial fibrosis in unilateral served in mice with intact OPN. In addition, the struc-
tural damage caused by ischemia of kidneys obtainedureteral obstruction and that the effect of OPN may be
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from OPN/ mice was more pronounced than that found markedly in PCNA-positive regenerative proximal
and distal tubules on days 10, 15 and 30. Double stainingobserved in similarly treated OPN/ mice. This could
be associated with the augmented expression of inducible for OPN and PCNA indicated that the PCNA-positive
cells were almost always accompanied by the up-regu-nitric oxide synthase (iNOS) in kidneys from OPN/
mice versus their OPN/ counterparts [77]. OPN in- lated expression of OPN. This result suggested that OPN
is related to the proliferation and regeneration of tubularhibits iNOS mRNA and protein levels and suppresses
nitric oxide (NO) synthesis induced by the inflammatory epithelial cells in the recovery process following tubular
damage [20].mediators -interferon and lipopolysaccharide in pri-
mary mouse kidney proximal tubule epithelial cells. This These studies, especially the comparative analysis of
functional and morphological sequelae in OPN/ andprocess is blocked by anti-OPN antiserum and by the
peptide GRGDS, but not GRGES. NO is believed to OPN/mice, provide strong evidence for the renopro-
tective action of OPN in renal injury.control blood flow through the glomerulus, regulating
salt and water balance [78]. In vitro, NO synthesis was
found to be significantly reduced when rat mesangial
OPN RECEPTORS IN THE KIDNEY
cells were plated on OPN-coated dishes compared to
It has been demonstrated that OPN receptors includetype I or IV collagen-coated dishes. Furthermore, anti-
two families of integrin [21] and CD44 [22], which areOPN antibodies increased NO synthesis in mesangial
ubiquitous multistructural and multifunctional trans-cells. iNOS mRNA levels were increased by tumor ne-
membrane glycoproteins that mediate cell-cell and cell-crosis factor-, and abruptly diminished after OPN
matrix interactions.mRNA was significantly induced [79]. These results sug-
The OPN integrin receptors include v3, v1, v5gest that OPN may be an important regulator of the NO
[21, 82] and 91 [83], and 41 [84]. In human kidneys,signaling pathway and NO-mediated cytotoxic processes.
v3 is expressed in glomerular epithelial cells, Bowman’sOsteopontin also can reduce cell peroxide levels, and
capsule, vascular endothelium, and weakly in tubularpromote the survival of cells exposed to hypoxia [80].
epithelial cells. v5 has a similar distribution, except forIn vitro studies with proximal tubular cells subjected to
minimal expression on the vascular endothelium. 1 ex-hypoxia resulted in cytoprotection in the presence of
pression is seen in glomerular epithelial cells, Bowman’sOPN, but not OPN with a deleted RGD domain [77].
capsule, the vascular epithelium and tubular epithelialIn addition, obstructed kidneys from OPN/ mice
cells [85]. Using neutralizing antibodies, all integrin-typehave more interstitial and tubular apoptotic cells (TUNEL
OPN receptors, v3, v1, v5 and 91, and 41 wereassay) compared to those from OPN/mice. The abil-
found to support cellular adhesion to OPN. In contrast,ity of OPN to act as a cell survival factor also was docu-
only cells containing v3 integrin migrated towards anmented by showing that the apoptosis of serum-starved
OPN gradient, demonstrating that different functions ofNRK52E renal epithelial cells was markedly enhanced
OPN are mediated via distinct receptors [83, 84, 86].in the presence of a neutralizing anti-OPN antibody [19].
The CD44 family of cell surface glycoprotein receptorsRecently, OPN was reported to be associated with
is widely expressed in embryonic, normal adult, and neo-regeneration and repair in the kidney after renal isch-
plasms. CD44 has at least 20 multiple isoforms of differ-emia/reperfusion injury. In a model of renal ischemia,
ent molecular sizes (85 to 230 kD), such as standardthe OPN peptide and mRNA were clearly detected in
CD44, which is also known as hemopoietic CD44, variantregenerating proximal tubules, in addition to distal tu-
CD44 and epithelial CD44 [87]. In normal human kid-bule and medullary thick ascending limb [41]. In rats
neys, gene expression of the CD44 standard isoform andgiven left renal ischemia for 60 minutes and a right ne-
the CD44 variant isoforms 8 to 10 are detectable, andphrectomy, up-regulated expression of OPN was pre-
among them, the CD44 standard isoform is expresseddominantly associated with morphological regeneration
most dominantly [88], whereas the CD44 peptide isin proximal tubules. The expression reached a maximum
barely detectable in distal tubule using immunohisto-after five to seven days, and was higher in the outer stripe
chemistry [89, 90]. In normal rat kidneys, CD44 has beenof the outer medulla than in the cortex [43]. In another
reported to be detectable in resident glomerular macro-model, OPN mRNA was expressed in regenerating tu-
phages, parietal epithelial cells of Bowman’s capsule,bules three days after induction of acute ischemic injury.
medullary tubules, and occasional cortical tubules (thickAn immunoreactive OPN peptide continued to be local-
ascending limb of Henle’s loop and distal tubules) [91,ized in those tubules up to seven days after the injury
92]. In renal damage states, such as rat anti-Thy-1 glom-[81]. In our model of gentamicin-induced acute tubular
erulonephritis [91], rat crescentic glomerulonephritisnecrosis, OPN mRNA and protein were expressed only
[50], tubulointerstitial nephritis in kdkd mice [93] andin proliferating cell nuclear antigen (PCNA)-positive
acute ischemic renal injury [81], CD44 is up-regulatedcortical distal tubules, but not in necrotic proximal tu-
bules, until day 6 after the first administration, but were in areas of renal injury accompanying its ligand OPN or
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hyaluronan. In rat anti-Thy-1 nephritis, the expression gest that induction of OPN expression by TGF-1 and
EGF is via increased transcription of the OPN gene [100].of CD44 mRNA and its protein for the 90 kD isoform
on the surface of rat mesangial cells is restricted to the Data from an in vitro study indicated that endothelin-1
caused a modest, but reproducible, increase in OPNtransient period of mesangial cell proliferation, as shown
by double-staining with an antibody against the prolifer- mRNA in a rat mesangial cell-line [42]. In rat anti-GBM
glomerulonephritis, interleukin-1 (IL-1) receptor antag-ating cell nuclear antigen (PCNA). In models of cres-
centic glomerulonephritis and tubulointerstitial nephri- onist treatment significantly reduced OPN mRNA and
protein expression in glomeruli and tubules during eithertis, double staining showed coexpression of OPN and
CD44 in intrinsic renal cells in a crescent formation, such induction, or the established phase of the disease. In
vitro, the addition of IL-1 to the normal rat tubularas visceral and parietal epithelial cells, tubular epithelial
cells, infiltrating macrophages and T cells. Anti-OPN epithelial cell line, NRK52E, up-regulated OPN mRNA
and protein levels. The effect was dose-dependent andtreatment significantly inhibited the up-regulation of
OPN and CD44 [74]. In the recovery process following inhibited by the addition of an IL-1 receptor antagonist,
thus demonstrating that IL-1 directly up-regulates renalischemic or toxic injury, CD44 and OPN are expressed
in regenerating tubules [20, 81]. These data suggest that OPN expression [101]. In a rat model of acute ischemic
renal injury, pretreatment with insulin-like growth fac-the interaction of OPN and its receptor CD44 may partic-
ipate in the process of inflammation and recovery after tor-I (IGF-I) enhanced expression of OPN at an earlier
period (12 hours, 1 day, and 5 days) after ischemia [41].renal injury.
In addition, high protein and high cholesterol diets
induced an increase in renal OPN mRNA [102]. A high
REGULATION OF OPN EXPRESSION
salt concentration or salt crystals also enhanced OPN
IN THE KIDNEY
expression in intact kidneys or cultured renal cells [103].
Factors increasing OPN expression
Factors inhibiting OPN expressionOsteopontin is a secreted phosphoprotein initially iso-
lated from bone. Therefore, parathyroid hormone (PTH), As described above, OPN expression up-regulates
during stone formation and the inflammatory process invitamin D3, calcium and phosphate, which are strongly
associated with bone development and stone formation, the kidney. Therefore, some factors or drugs inhibiting
stone formation and inflammatory responses can de-increase OPN expression. In the kidneys of young rats in-
fused with PTH, OPN mRNA increased 15.3-fold com- crease OPN expression. In a renal stone formation model
administered glyoxylic acid and 1,25-(OH)2D3, the ex-pared with control rats [32]. In hypercalcemic rats in-
duced by treatment with a PTH-related peptide, OPN pression of OPN mRNA was markedly inhibited by con-
comitant administration of the female sex hormones,mRNA and protein were enhanced in distal tubular cells
[94]. Monkey renal epithelial cells (BSC-1 line) in a mono- estrogen, estradiol and/or progesterone [37, 104]. OPN
expression was enhanced in the distal tubular cells oflayer culture constitutively secreted OPN into the culture
medium. After addition of calcium oxalate monohydrate hypercalcemic rats treated with a PTH-related peptide
and was decreased by alendronate, a bisphosphonatecrystals to the medium, the net OPN content of the cul-
tures increased by 18% after 24 hours [95]. OPN is not derivative [94]. In UUO in rats, OPN mRNA and protein
were significantly increased, whereas enalapril, an angio-induced by 1,25-(OH)2D3 in the kidneys of D-deficient
rats. However, in vitamin D-replete rats given 1,25-(OH)2 tensin-converting enzyme (ACE) inhibitor, treatment
had no effect on the increase in OPN mRNA, but signifi-D3 for five days, OPN induction in the kidneys signifi-
cantly increased by 6.0-fold [96]. In addition, there is a cantly attenuated the increase in protein in tubular cells
compared to untreated animals [46]. Enalapril and/or ver-specific link between OPN induction and the enzymatic
activity of alkaline phosphatase, which results in the gen- apamil also blunted cyclosporine-induced OPN mRNA
expression significantly [105]. In subtotal (5/6) nephrec-eration of free phosphate. Increased free phosphate lev-
els can directly induce strong and specific induction of tomy rats, treatment with either valsartan, an angiotensin
II type I receptor antagonist, or ramipril, an ACE inhibitorOPN mRNA and protein in the culture medium [97].
Many cytokines increase OPN expression. Tumor ne- completely abrogated the up-regulation of OPN mRNA
and protein expression in glomeruli and tubules [52].crosis factor- (TNF-) and platelet-derived growth fac-
tor (PDGF) increase OPN gene and protein expression Since a high salt concentration or salt crystals are
known to enhance OPN expression in intact kidneys orin serum-starved cultured rat mesangial cells [98, 99]. In
cultured NRK52E cells, a rat renal epithelial cell line, cultured renal cells, it is clear that a low salt condition
decreases OPN expression in the kidneys. In rats fed atransforming growth factor-1 (TGF-1) and epidermal
growth factor (EGF) were potent inducers of OPN sodium-deficient diet for one week, there was a marked
decrease in OPN protein immunoreactivity in the de-mRNA and protein in those cells. The results from OPN
mRNA stability analysis and nuclear run-on assays sug- scending thin limbs of Henle’s loop, but no changes in
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